A nonsense polymorphism in the protein Z-dependent protease inhibitor increases the risk for venous thrombosis

Blood

Volumn 108, Issue 1, 2006, Pages 177-183

  Corral, Javier ^a   González Conejero, Rocio ^b   Soria, Jose Manuel ^b   González Porras, Jose Ramón ^b   Pérez Ceballos, Elena ^b   Lecumberri, Ramón ^b   Roldán, Vanessa ^b   Souto, Juan Carlos ^b   Miñano, Antonia ^b   Hernández Espinosa, David ^b   Alberca, Ignacio ^b   Fontcuberta, Jordi ^b   Vicente, Vicente ^b  

^a HOSPITAL UNIVERSITARIO MORALES MESEGUER   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; FATTY ACID BINDING PROTEIN; GLYCINE; LYSINE; PROTEINASE INHIBITOR; PROTHROMBIN; SERINE;

ARTICLE; CASE CONTROL STUDY; CLINICAL FEATURE; CODON; CONTROLLED STUDY; DNA MODIFICATION; ENZYME POLYMORPHISM; FEMALE; GENE; GENE IDENTIFICATION; GENETIC CODE; GENETIC VARIABILITY; HAPLOTYPE; HOMOZYGOSITY; HUMAN; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RISK FACTOR; VEIN THROMBOSIS; ZPI GENE;

EID: 33745627306     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2005-08-3249     Document Type: Article

References (30)

1. Franco RF, Reitsma PH. Genetic risk factors of venous thrombosis. Hum Genet. 2001;109:369-384.
2. Zoller B, Garcia de Frutos P, Hillarp A, Dahlback B. Thrombophilia as a multigenic disease. Haematologica. 1999;84:59-70.
3. Lane DA, Grant PJ. Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease. Blood. 2000;95:1517-1532.
4. Han X, Huang ZF, Fiehler R, Broze GJ Jr. The protein Z-dependent protease inhibitor is a serpin. Biochemistry. 1999;38:11073-11078.
5. Han X, Fiehler R, Broze GJ Jr. Characterization of the protein Z-dependent protease inhibitor. Blood. 2000;96:3049-3055.
6. Heeb MJ, Cabral KM, Ruan L. Down-regulation of factor IXa in the factor Xase complex by protein Z-dependent protease inhibitor. J Biol Chem. 2005;280:33819-33825.
7. Yin ZF, Huang ZF, Cui J, et al. Prothrombotic phenotype of protein Z deficiency. Proc Natl Acad Sci U S A. 2000;97:6734-6738.
8. Van de Water N, Tan T, Ashton F, et al. Mutations within the protein Z-dependent protease inhibitor gene are associated with venous thromboembolic disease: a new form of thrombophilia. Br J Haematol. 2004;127:190-194.
9. Corral J, Zuazu-Jausoro I, Rivera J, Gonzalez-Conejero R, Ferrer F, Vicente V. Clinical and analytical relevance of the combination of prothrombin 20210A/A and factor V Leiden: results from a large family. Br J Haematol. 1999;105:560-563.
10. Cornfield J. A method of estimating comparative rates from clinical data: applications to cancer of the lung, breast, and cervix. J Natl Cancer Inst. 1951;11:1269-1275.
11. Weir BS. Genetic Data Analysis II. Sunderland, MA: Sinauer Associates; 1996.
12. Meng Z, Zaykin DV, Xu CF, Wagner M, Ehm MG. Selection of genetic markers for association analysis using linkage disequilibrium and haplotypes. Am J Hum Genet. 2003;73:115-130.
13. Zhao JH, Lissarrague S, Essioux L, Sham PC. GENECOUNTING: haplotype analysis with missing genotypes. Bioinformatics. 2002;18:1694-1695.
14. Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet. 2002;70:425-434.
15. Gonzalez-Conejero R, Perez-Ceballos E, Vicente V, Corral J. Protein Z-dependent protease inhibitor W303X mutation in venous thrombosis. Br J Haematol. 2005;129:561-562.
16. National Center for Biotechnology Information. Single Nucleotide Polymorphisms database. http://www.ncbi.nlm.nih.gov/projects/SNP/index.html. Accessed January 31, 2006.
17. Baglin TP, Carrell RW, Church FC, Esmon CT, Huntington JA. Crystal structures of native and thrombin-complexed heparin cofactor II reveal a multistep allosteric mechanism. Proc Natl Acad Sci U S A. 2002;99:11079-11084.
18. Silverman GA, Bird PI, Carrell RW, et al. The serpins are an expanding superfamily of structurally similar but functionally diverse proteins: evolution, mechanism of inhibition, novel functions, and a revised nomenclature. J Biol Chem. 2001;276:33293-33296.
19. Carrell R, Corral J. What can Drosophila tell us about serpins, thrombosis and dementia? Bioessays. 2004;26:1-5.
20. Corral J, Vicente V, Carrell RW. Thrombosis as a conformational disease. Haematologica. 2005;90:238-246.
21. Forastiero RR, Martinuzzo ME, Lu L, Broze GJ. Autoimmune antiphospholipid antibodies impair the inhibition of activated factor X by protein Z/protein Z-dependent protease inhibitor. J Thromb Haemost. 2003;1:1764-1770.
22. Al-Shanqeeti A, van Hylckama Vlieg A, Berntorp E, Rosendaal FR, Broze GJ Jr. Protein Z and protein Z-dependent protease inhibitor: determinants of levels and risk of venous thrombosis. Thromb Haemost. 2005;93:411-413.
23. Yang N, MacArthur DG, Gulbin JP, et al. ACTN3 genotype is associated with human elite athletic performance. Am J Hum Genet. 2003;73:627-631.
24. Hawn TR, Wu H, Grossman JM, Hahn BH, Tsao BP, Aderem A. A stop codon polymorphism of Toll-like receptor 5 is associated with resistance to systemic lupus erythematosus. Proc Natl Acad Sci U S A. 2005;102:10593-10597.
25. Eslami B, Kinboshi M, Inoue S, Harada K, Inoue K, Koizumi A. A nonsense polymorphism (Y319X) of the solute carrier family 6 member 18 (SLC6A18) gene is not associated with hypertension and blood pressure in Japanese. Tohoku J Exp Med. 2006;208:25-31.
26. Calin GA, Trapasso F, Shimizu M, et al. Familial cancer associated with a polymorphism in ARLTS1. N Engl J Med. 2005;352:1667-1676.
27. Kira R, Ihara K, Watanabe K, et al. Molecular epidemiology of C9 deficiency heterozygotes with an Arg95Stop mutation of the C9 gene in Japan. J Hum Genet. 1999;44:109-111.
28. Carrell RW, Lomas DA. Alpha1-antitrypsin deficiency: a model for conformational diseases. N Engl J Med. 2002;346:45-53.
29. Corral J, Aznar J, Gonzalez-Conejero R, et al. Homozygous deficiency of heparin cofactor II: relevance of P17 glutamate residue in serpins, relationship with conformational diseases, and role in thrombosis. Circulation. 2004;110:1303-1307.
30. Ishiguro K, Kojima T, Kadomatsu K, et al. Complete antithrombin deficiency in mice results in embryonic lethality. J Clin Invest. 2000;106:873-878.